drugset / Trial / NCT05035342
Fecal Transplantation to Eradicate Colonizing Emergent Superbugs
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
Carriage of multi-drug and extensive-drug resistant Gram negative bacteria (MDR-GNB) is associated with an increased risk of infections by these bacteria for the carriers and a high risk of dissemination both in the healthcare setting and the community; the main MDR-GNB reservoir is the fecal microbiota. To prevent both infections and dissemination, effective measures to decolonize subjects carrying MDR-GNB are urgently needed. Animal models, case reports and cohort studies suggest fecal microbiota transplantation (FMT) may be efficient for MDR-GNB decolonization.
Timeline
- Start
- 2024-01-11
- Primary completion
- 2026-05
- Completion
- 2028-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fecal Microbiota Transplantation (FMT) | Other / unclassified | 50 g | — |